Support for distressed medical residents and faculty

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the effectiveness of an anonymous online screening tool for stress, depression, substance use, and suicidal thoughts among medical residents, fellows, and faculty at Oregon Health and Science University. Participants will complete the screening and have the opportunity to interact with a clinician online, which is expected to encourage them to seek in-person counseling. The study is based on motivational interviewing and aims to reduce suicide risk factors by increasing the willingness to seek help. The program is part of a broader initiative to promote mental health awareness and support within the medical community.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* OHSU medical residents, fellows, and full-time School of Medicine faculty

Exclusion Criteria:

* individuals not meeting the above inclusion criteria

Where it's running

• Oregon Health and Science University
  Portland, Oregon, United States Recruiting

Study contacts

• Principal investigator: Marie V Soller, MD — Oregon Health and Science University
• Study coordinator: Marie V Soller, MD
• Email: soller@ohsu.edu
• Phone: 503-494-9000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Sleep and circadian interventions for college students at high risk of suicide

  Three sleep-focused approaches are being tested to see if they can help reduce suicidal thoughts and depression in high-risk college students receiving psychiatric care.

  Recruiting University of Pittsburgh · Pittsburgh, Pennsylvania · NCT07346014

• Sleep and bright-light program for teens with depression and sleep problems

  This project will try a sleep-and-bright-light program to improve sleep and mood in teens aged 12–18 with moderate-to-severe depression and clinically significant sleep problems who are at risk for suicidal thoughts.

  Recruiting at 2 sites University of Pittsburgh · Philadelphia, Pennsylvania and 1 other locations · NCT06963463

• Testing a new drug for treatment-resistant depression

  This study is testing a new drug called HNK to see if it can help people with treatment-resistant depression feel better when other medications haven't worked.

  Recruiting Phase 2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06511908

• Online cognitive behavioral therapy for preventing suicide and treating depression

  This study is testing two online therapy courses for veterans to see if they can help with depression and suicidal thoughts.

  Recruiting Phase 2 VA Eastern Colorado Health Care System · Aurora, Colorado · NCT06375083

• Using ketamine to help suicidal patients in the emergency department

  This study is testing if a low dose of ketamine can safely help people in the emergency department who are feeling suicidal by reducing their symptoms and possibly shortening their hospital stay.

  Recruiting Phase 1 University of Kansas Medical Center · Kansas City, Kansas and 1 other locations · NCT06085937

• Examining brain connectivity in suicidal opioid users

  This study is trying to see if a brain stimulation treatment can help reduce cravings and suicidal thoughts in people who use opioids.

  Recruiting Baylor College of Medicine · Houston, Texas · NCT05489042

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.